These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23122818)

  • 21. Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells.
    Bartel K; Müller R; von Schwarzenberg K
    J Biol Chem; 2019 Nov; 294(46):17239-17248. PubMed ID: 31604821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.
    Hamm R; Sugimoto Y; Steinmetz H; Efferth T
    Invest New Drugs; 2014 Oct; 32(5):893-903. PubMed ID: 25065443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids.
    Rivière S; Vielmuth C; Ennenbach C; Abdelrahman A; Lemke C; Gütschow M; Müller CE; Menche D
    ChemMedChem; 2020 Jul; 15(14):1348-1363. PubMed ID: 32363789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
    Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
    J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
    Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
    Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
    Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K
    Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
    Schneider LS; von Schwarzenberg K; Lehr T; Ulrich M; Kubisch-Dohmen R; Liebl J; Trauner D; Menche D; Vollmar AM
    Cancer Res; 2015 Jul; 75(14):2863-74. PubMed ID: 26018087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of photoactivatable acyclic analogues of the lobatamides.
    Shen R; Inoue T; Forgac M; Porco JA
    J Org Chem; 2005 Apr; 70(9):3686-92. PubMed ID: 15845008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and V-ATPase inhibition of simplified lobatamide analogues.
    Shen R; Lin CT; Bowman EJ; Bowman BJ; Porco JA
    Org Lett; 2002 Sep; 4(18):3103-6. PubMed ID: 12201727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity.
    van der Poel S; Wolthoorn J; van den Heuvel D; Egmond M; Groux-Degroote S; Neumann S; Gerritsen H; van Meer G; Sprong H
    Traffic; 2011 Nov; 12(11):1634-47. PubMed ID: 21810155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of V-ATPases: old and new players.
    Huss M; Wieczorek H
    J Exp Biol; 2009 Feb; 212(Pt 3):341-6. PubMed ID: 19151208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vacuolar ATPase as a drug discovery target.
    Niikura K
    Drug News Perspect; 2006 Apr; 19(3):139-44. PubMed ID: 16804565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis of archazolid A.
    Menche D; Hassfeld J; Li J; Rudolph S
    J Am Chem Soc; 2007 May; 129(19):6100-1. PubMed ID: 17455939
    [No Abstract]   [Full Text] [Related]  

  • 35. Callyspongiolide Is a Potent Inhibitor of the Vacuolar ATPase.
    Fogarty S; Ouyang Y; Li L; Chen YC; Rane H; Manoni F; Parra KJ; Rutter J; Harran PG
    J Nat Prod; 2020 Nov; 83(11):3381-3386. PubMed ID: 33151675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMT.
    Merk H; Messer P; Ardelt MA; Lamb DC; Zahler S; Müller R; Vollmar AM; Pachmayr J
    Mol Cancer Ther; 2017 Nov; 16(11):2329-2339. PubMed ID: 28775146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity studies of the V-ATPase inhibitor saliphenylhalamide (SaliPhe) and simplified analogs.
    Garcia-Rodriguez J; Mendiratta S; White MA; Xie XS; De Brabander JK
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4393-8. PubMed ID: 26372654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palmerolide macrolides from the Antarctic tunicate Synoicum adareanum.
    Noguez JH; Diyabalanage TK; Miyata Y; Xie XS; Valeriote FA; Amsler CD; McClintock JB; Baker BJ
    Bioorg Med Chem; 2011 Nov; 19(22):6608-14. PubMed ID: 21737286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revealing the macromolecular targets of complex natural products.
    Reker D; Perna AM; Rodrigues T; Schneider P; Reutlinger M; Mönch B; Koeberle A; Lamers C; Gabler M; Steinmetz H; Müller R; Schubert-Zsilavecz M; Werz O; Schneider G
    Nat Chem; 2014 Dec; 6(12):1072-8. PubMed ID: 25411885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total synthesis of bafilomycin A1.
    Kleinbeck F; Fettes GJ; Fader LD; Carreira EM
    Chemistry; 2012 Mar; 18(12):3598-610. PubMed ID: 22344969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.